Patterson Charles E, Abrams William R, Wolter Nikolaus E, Rosenbloom Joel, Davis Elaine C
Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas 75390-9039, USA.
Cell Stress Chaperones. 2005 Winter;10(4):285-95. doi: 10.1379/csc-118r.1.
AFKBP65 (65-kDa FK506-binding protein) is an endoplasmic reticulum (ER)-localized peptidyl-prolyl cis-trans isomerase predicted to play a role in the folding and trafficking of secretory proteins. In previous studies, we have shown that FKBP65 is developmentally regulated and associates with the extracellular matrix protein, tropoelastin, during its maturation and transport through the ER. In this study, we show that FKBP65 is expressed in the lung with the same developmental pattern as tropoelastin and other matrix proteins. To test the hypothesis that FKBP65 is upregulated at times when extracellular matrix proteins are being actively synthesized and assembled, adult mice were treated with bleomycin to cause reinitiation of matrix protein production during the ensuing development of pulmonary fibrosis. After bleomycin instillation, FKBP65 expression was reactivated in the lung with a pattern similar to that observed for tropoelastin and type I collagen. Using human lung fibroblast cultures, we showed that FKBP65 does not undergo the unfolded protein response, a response associated with an upregulation of resident ER proteins that occurs after increased ER stress. When fibroblasts were treated with transforming growth factor (TGF)-beta1, which is upregulated during the development of pulmonary fibrosis and known to induce matrix production, FKBP65 expression and synthesis was also increased. Similar to type I collagen and tropoelastin, this response was completely inhibited in a dose-dependent manner by GGTI-298, a geranylgeranyl transferase I inhibitor. Treatment of fibroblasts with an inhibitor of ribonucleic acid (RNA) polymerase II after TGF-beta1 treatment showed that the effect of TGF-beta1 was not because of increased stabilization of the FKBP65 messenger RNA. In summary, we have shown that FKBP65 is highly expressed in lung development, downregulated in the adult, and can be reactivated in a coordinated manner with extracellular matrix proteins after lung injury. The expression pattern of FKBP65, which is atypical for general ER foldases, suggests that FKBP65 has a distinct set of developmentally regulated protein ligands. The response to injury, which may be in part a direct response to TGF-beta1, assures the presence of FKBP65 in the ER of cells actively producing components of the extracellular matrix.
AFKBP65(65千道尔顿FK506结合蛋白)是一种定位于内质网(ER)的肽基脯氨酰顺反异构酶,预计在分泌蛋白的折叠和运输中发挥作用。在先前的研究中,我们已经表明FKBP65在发育过程中受到调控,并且在原弹性蛋白成熟并通过内质网运输期间与细胞外基质蛋白原弹性蛋白相关联。在本研究中,我们表明FKBP65在肺中的表达模式与原弹性蛋白和其他基质蛋白相同。为了验证FKBP65在细胞外基质蛋白被积极合成和组装时上调的假设,成年小鼠用博来霉素处理,以在随后的肺纤维化发展过程中重新启动基质蛋白的产生。博来霉素滴注后,FKBP65在肺中的表达被重新激活,其模式与原弹性蛋白和I型胶原相似。使用人肺成纤维细胞培养物,我们表明FKBP65不会经历未折叠蛋白反应,这种反应与内质网应激增加后内质网驻留蛋白的上调有关。当成纤维细胞用转化生长因子(TGF)-β1处理时,TGF-β1在肺纤维化发展过程中上调并且已知可诱导基质产生,FKBP65的表达和合成也增加。与I型胶原和原弹性蛋白相似,这种反应被香叶基香叶基转移酶I抑制剂GGTI-298以剂量依赖性方式完全抑制。TGF-β1处理后用核糖核酸(RNA)聚合酶II抑制剂处理成纤维细胞表明,TGF-β1的作用不是由于FKBP65信使RNA的稳定性增加。总之,我们已经表明FKBP65在肺发育中高度表达,在成年期下调,并且在肺损伤后可以与细胞外基质蛋白以协调的方式重新激活。FKBP65的表达模式对于一般的内质网折叠酶来说是非典型的,这表明FKBP65具有一组独特的受发育调控的蛋白质配体。对损伤的反应,这可能部分是对TGF-β1的直接反应,确保了FKBP65在积极产生细胞外基质成分的细胞内质网中的存在。